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Introduction 
It has been documented that the T-cell costimulation
and lymphocyte migration play the central role in the
inflammatory process [1]. Adhesion molecules, among
others are suggested as the inflammatory markers of
diabetic micro- and macroangiopathy [2,3]. ICAM-
1/LFA-1 adhesion molecules not only participate in the
lymphocyte T proliferation but also mediate leukocyte
migration to the site of inflammation [1]. In our previ-
ous study we have demonstrated that the percentage of
PBTLs expressing costimulatory molecules
CD28/CTLA-4 was altered in children/adolescents
with T1D and with vascular complications [4]. 
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Abstract: There are only few studies evaluating lymphocytes activation in the diabetic vascular complications. 
ICAM-1/LFA-1 adhesion molecules not only participate in the lymphocyte T proliferation but also mediate leukocyte migra-
tion to the site of inflammation. We assess a relationship between the percentage of ICAM-1 and LFA-1 expressing PBMCs
and the evolution of vascular complications in  T1D in children and adolescents. The study was carried out on  60 children
and adolescents with T1D (aged 9-20): (a) T1D lasting <5 years (n=20), (b) T1D lasting >5 years (n=20), without compli-
cations c) T1D lasting >5 years complicated with microalbuminuria, arterial hypertension, diabetic retinopathy (20 n). 
20 healthy volunteers, age and sex matched constituted the control group. The expression of adhesion molecules was eval-
uated by using three-color flow cytometry. In children and adolescents with T1D <5 years, the percentage of ICAM-1+ and
LFA-1+ PBMCs was decreased vs. controls (p<0.05 and p<0.001, respectively). Both in patients with T1D>5 years without
vascular complications and in T1D with vascular disease the percentage of LFA-1+ T lymphocytes was significantly reduced
in the peripheral blood (p<0.001 vs. healthy controls). In conclusion the percentage of LFA-1+ and ICAM-1+ PBMCs does
not distinguish patients with vascular complications however decreased percentage of LFA-1+ PMBCs could serve as a non-
specific marker of the development of local inflammatory process in Type 1 diabetes. 
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Recently an increasing number of studies indicate
the genetic influence of ICAM-1 polymorphism in
development of the T1D and vascular complications
[5,6]. Many reports documented an elevated serum
concentrations of sICAM-1 and vascular adhesion
molecules in patients with diabetes and microvascular
disease [7-12]. Nevertheless, data on the expression of
ICAM-1+/LFA-1+ peripheral blood mononuclear cells
in children/adolescents with Type 1 diabetes with vas-
cular complications is lacking.    
In the present study: (a) we examined the expres-
sion of LFA-1 on T lymphocytes and the expression of
ICAM-1 on monocytes in the course of Type 1 dia-
betes in children and adolescents; (b) we assessed a
relationship between the percentage of PBMCs
expressing ICAM-1 and, LFA-1 and the development
of diabetic vascular complications (microalbuminuria,
diabetic retinopathy and arterial hypertension).
Materials and methods
Patients. Three groups of 60 Caucasian children and adolescents
(aged 9-20 years), were randomly selected from the Second
Department of Children's Diseases, Medical University of Bia-
lystok. Type 1 diabetes mellitus was diagnosed according to WHO
criteria.   
1. 20 children (10F and 10M) with T1D<5 years (mean 3±0.97),
aged 9-19 (mean 14.9±2.7); 
2. 20 children  (8F and 12M), with T1D>5 years (mean 8±1.95),
aged 11-20 (mean 14.5±2.4); without complications;
3. 20 children (9F and 11M), with T1D>5 years (mean
9.45±2.87), aged 12-20 (mean 17.1±2.5), and with vascular
complications: microalbuminuria, arterial hypertension, dia-
betic retinopathy (9 children had one vascular complication, 8
subjects two complications and 3 subjects had all complica-
tions). All patients were under intensive insulin therapy.
Presence of diabetic retinopathy, arterial hypertension and
incipient nephropathy-microalbuminuria were diagnosed accord-
ing to the standards of American Diabetes Association [13].
Presence of diabetic retinopathy was diagnosed after pupil
dilation on basis of direct and indirect ophthalmoscopy and con-
firmed by fluorescein angiography. Arterial hypertension was
found when 30% of Ambulatory Blood Pressure Monitoring
(ABPM) values were over 95 percentile according to age and sex
tables for blood pressure. For a diagnosis of diabetic nephropathy,
a urinary albumin excretion rate (UAE) of 20-200 μg/min or
>30mg/24h from at least two subsequent specimens was classified
as microalbuminuria after exclusion of urinary infection.    
Control group consisted of 20 healthy volunteers, (13 F and 7
M), aged 6-17 (mean 14ˆ3.1), with no family history of insulin-
dependent diabetes or other autoimmune diseases. Written
informed consent was obtained and the protocol for the study was
approved by the Local Ethics Committee.
Flow cytometric analysis. Briefly, 100 μL samples of whole blood
were stained with 10 μL of the following tree-color mAb: (Simul-
test, Becton Dickinson Immunocytometry System, San Jose, CA,
USA) CD3-PerCP; CD3-PerCP/CD11a-FITC; CD14-FITC/CD54-
PE. After incubation at room temperature for 20 min, the samples
were than processed with a 35s cycle on rapid no-wash whole
blood lysis work station. A minimum of 104 cells of the evaluated
subset were analysed for each sample on Coulter EPICS XL flow
cytometer. The PBMCs' subpopulations were calculated by the
software. The total numbers of leukocytes, lymphocytes and
monocytes in the peripheral blood were measured by Coulter
MAXM haematological counter. 
Isotype-identical mAbs served as controls (IgG1-FITC/IgG2b-
PE). The percentage of positive cells was determined by setting the
lower limit over the non-specific fluorescence with suitable con-
trols. 
Assessment of HbA1c concentrations. HbA1c was quantified in
diluted and K2EDTA serum by liquid chromatography technique
HPLC – Variant (Bio-Rad). 
Statistical analysis. Results are presented as median (range). Kol-
mogorov-Smirnof' test, Kruskal-Wallis test and Spearman's rank
correlation test were used. A p value of less than 0.05 was consid-
ered statistically significant. All data were performed using Statis-
tica 6.0 (StatSoft, Tulsa, OK, U.S.A.).
Results
Metabolic control: HbA1c
The values of HbA1c were higher in the groups of
T1D>5 years with and without vascular complications
than in T1D<5 years (8% and 8.2%, vs. 7.9%; respec-
tively). However no statistical difference was
observed. 
The percentage of PBMCs expressing 
ICAM-1/LFA-1 
Subjects with T1D lasting <5 years showed both a
decreased percentage of PBMCs expressing ICAM-1
and LFA-1 molecules (p<0.05 and p<0.001 vs. con-
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Table 1. Median values of the percentage of PBMCs expressing LFA-1, ICAM-1 in the evaluated groups (*p<0.05 T1D<5 years vs.
T1D>5 years without vascular complications and vs. controls, **p<0.01 T1D>5 years and without vascular complications vs. controls,
***p<0.001 T1D<5 years and lasting >5 years without vascular complications vs. controls).
trols respectively) (Table 1). The difference between
the median percentage of ICAM-1+ PBMCs in chil-
dren with T1D<5 years and in children with T1D>5
years without vascular complications was statistical-
ly significant (p<0.05) (Table 1, Fig. 2).
In subjects suffering from T1D lasting >5 years
without complications and with vascular complica-
tions disease only a decreased percentage of LFA-1+
PBTLs was observed (p<0.001 vs. healthy controls
respectively) (Table 1, Fig. 2). 
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Fig. 1. Flow cytometric dot plots of PBMCs from a representative patient. (A) Scatter plot of lymphocytes pregating by light properties;
(B) gating of CD3+PerCP (T lymphocytes population) and its subsets (CD3+PerCP;  CD3+PerCP/CD11a+FITC), (C); (D) CD14+FITC
monocytes SSC gating; (E) The subpopulation of CD14+FITC/CD54+PE peripheral blood monocytes. The percentage of positive cells
was determined by setting the lower limit over the non-specific fluorescence with suitable controls.
Fig. 2. The expression of ICAM-1 on peripheral blood monocytes and LFA-1 on PBTLs in the evaluated groups with Type 1 diabetes
mellitus.
Discussion
In our previous studies, we observed the decreased
percentage of VLA-4+ and CD28+ PBTLs in children
with T1D lasting <5 years [4-14]. The diminished
expression of LFA-1 and ICAM-1 on the PBMCs may
be due to the tapping of these cells expressing adhe-
sion molecules into the site of inflammation and hence
their lack in the circulation [15]. Both the elevation in
serum and the reduced membrane expression can
result from increased shedding of LFA-1 and ICAM-1
molecules and reflect the ongoing immune process
[4,15]. 
Earlier studies, documented the elevated serum
concentrations of sICAM-1 and sVCAM-1 in the dia-
betic complications indicating an endothelial dysfunc-
tion [9-12].
Many authors have suggested that the vascular dis-
ease starts early in the course of childhood diabetes
and that the adhesion molecules participate in the dia-
betic micro- and macroangiopathy [9,11,12]. 
In our recent report, suggesting PBMCs activation,
we have documented that the percentage of PBLTs
expressing L-selectin was increased in Type 1 diabetic
children, especially in subjects with vascular compli-
cations, while the percentage of VLA-4+ PBLTs was
decreased only in children without vascular complica-
tions [14]. We concluded that the proportion of L-
selectin+ and VLA-4+ PBTLs might be considered as
an early non-specific marker of diabetic microvascular
complications or arterial hypertension.
This notion may be supported by the results of
Targer et al. indicating that the level of sICAM-1 was
significantly increased in T1D without a clinically
overt macrovascular disease, moreover it was even
higher in the advanced microvascular complications
[16]. 
There are only few studies evaluating lymphocytes
activation in the diabetic vascular complications
[4,14,17,18]. Shestakova et al. found an increased per-
centage of ICAM-1+ lymphocytes and granulocytes in
patients with microalbuminuria and especially neovas-
cularization. These findings showed not only endothe-
lium but also leukocytes activation at early disease
stages [17]. Increased counts of T lymphocytes and
high expression of ICAM-1 in ocular tissues of diabet-
ics, suggest an important role of these factors in
recruitment of this cells at the site of microvascular
lesions [3,18-20].
In conclusion, the percentage of ICAM-1+ and
LFA-1+ PBMCs does not distinguish patients with vas-
cular complications however decreased LFA-1+
PMBCs percentage could serve as a non-specific
marker of the local inflammatory process in T1D.
Nevertheless, since for all surface markers there is a
substantial overlapping in the evaluated groups the
study needs further analysis. 
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